ConductScience.org, home

Paper40972018

Development of a murine tumor-infiltrating lymphocyte therapy model for cholangiocarcinoma.

Wittling MC and 9 others. J Immunol, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Development of a murine tumor-infiltrating lymphocyte therapy model for cholangiocarcinoma. Papers, record 40972018. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40972018

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Development of a murine tumor-infiltrating lymphocyte therapy model for cholangiocarcinoma.
PubMed
Journal
J Immunol
PubMed
Year
2026
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-09-18
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wittling MCMegen C
2Bennett FJFrances Jhttps://orcid.org/0000-0002-2650-9337
3Warren EAKEmilie A K
4Oppat KMKailey M
5Wyatt MMMegan M
6Hammons JNJacklyn N
7Liu YYuanhttps://orcid.org/0000-0001-8926-3058
8Maithel SKShishir K
9Paulos CMChrystal M
10Lesinski GBGregory B

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Lymphocytes, Tumor-InfiltratingMajor topic
CholangiocarcinomaMajor topic
Bile Duct NeoplasmsMajor topic
Immunotherapy, AdoptiveMajor topic
Animals
Mice
Disease Models, Animal
Cell Line, Tumor
Humans
Antigens, Neoplasm
Female
CD3 Complex
Mice, Inbred C57BL

Source PubMed

Download CSV of topics

Grants29

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R21CA270903NCI NIH HHSUnited StatesR21CA270903PubMedNIH RePORTER
R01 CA208514NCI NIH HHSUnited StatesR01CA208514PubMedNIH RePORTER
1F30CA291027-01A1NCI NIH HHSUnited StatesF30CA291027PubMedNIH RePORTER
TL1 TR002382NCATS NIH HHSUnited StatesTL1TR002382PubMedNIH RePORTER
R01CA275199NCI NIH HHSUnited StatesR01CA275199PubMedNIH RePORTER
TL1TR002382NIH HHSUnited StatesTL1TR002382PubMedNIH RePORTER
F30 CA291027NCI NIH HHSUnited StatesF30CA291027PubMedNIH RePORTER
R21 CA266088NCI NIH HHSUnited StatesR21CA266088PubMedNIH RePORTER
V Foundation and Emory UniversityPubMedPubMed
UL1 TR002378NCATS NIH HHSUnited StatesUL1TR002378PubMedNIH RePORTER
NIH HHSUnited StatesPubMedPubMed
T32 CA272392-01A1NCI NIH HHSUnited StatesT32CA272392PubMedNIH RePORTER
Cholangiocarcinoma FoundationPubMedPubMed
R01 CA275199NCI NIH HHSUnited StatesR01CA275199PubMedNIH RePORTER
R01 CA228406NCI NIH HHSUnited StatesR01CA228406PubMedNIH RePORTER
R21 CA270903NCI NIH HHSUnited StatesR21CA270903PubMedNIH RePORTER
R01CA228406NCI NIH HHSUnited StatesR01CA228406PubMedNIH RePORTER
UL1TR002378NIH HHSUnited StatesUL1TR002378PubMedNIH RePORTER
Abraham and Phyllis Katz FoundationPubMedPubMed
R01CA208514NCI NIH HHSUnited StatesR01CA208514PubMedNIH RePORTER

See all 29 grantsDownload CSV of grants

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112242449Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes.Science2002https://conductscience.org/library/papers/12242449PubMed
238550594Adoptive T cell therapy for solid tumors: current landscape and future challenges.Front Immunol2024https://conductscience.org/library/papers/38550594PubMed
332008328Immune checkpoint inhibitor therapy in biliary tract cancer (cholangiocarcinoma).Chin Clin Oncol2020https://conductscience.org/library/papers/32008328PubMed
424812403Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer.Science2014https://conductscience.org/library/papers/24812403PubMed
540234732Publisher Correction: Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trial.Nat Med2025https://conductscience.org/library/papers/40234732PubMed
636928584Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study.Signal Transduct Target Ther2023https://conductscience.org/library/papers/36928584PubMed
716715430Intrahepatic cholangiocarcinoma with lymph node metastasis successfully treated by immunotherapy with CD3-activated T cells and dendritic cells after surgery: report of a case.Surg Today2006https://conductscience.org/library/papers/16715430PubMed
838625642Lifileucel: First Approval.Mol Diagn Ther2024https://conductscience.org/library/papers/38625642PubMed
915980149Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells.Proc Natl Acad Sci U S A2005https://conductscience.org/library/papers/15980149PubMed
1028522749Expansion of Tumor-Infiltrating CD8+ T cells Expressing PD-1 Improves the Efficacy of Adoptive T-cell Therapy.Cancer Res2017https://conductscience.org/library/papers/28522749PubMed
1122745104Improved statistical modeling of tumor growth and treatment effect in preclinical animal studies with highly heterogeneous responses in vivo.Clin Cancer Res2012https://conductscience.org/library/papers/22745104PubMed
1231207604TOX is a critical regulator of tumour-specific T cell differentiation.Nature2019https://conductscience.org/library/papers/31207604PubMed
1325428507Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens.Nature2014https://conductscience.org/library/papers/25428507PubMed
1438458319Syngeneic murine models with distinct immune microenvironments represent subsets of human intrahepatic cholangiocarcinoma.J Hepatol2024https://conductscience.org/library/papers/38458319PubMed
1539199630Strategies for Improving CAR T Cell Persistence in Solid Tumors.Cancers (Basel)2024https://conductscience.org/library/papers/39199630PubMed
1633276030CD40-mediated immune cell activation enhances response to anti-PD-1 in murine intrahepatic cholangiocarcinoma.J Hepatol2021https://conductscience.org/library/papers/33276030PubMed
1734408920Modeling ex vivo tumor-infiltrating lymphocyte expansion from established solid malignancies.Oncoimmunology2021https://conductscience.org/library/papers/34408920PubMed
1837722960Intrahepatic cholangiocarcinoma: Evolving strategies in management and treatment.Dig Liver Dis2024https://conductscience.org/library/papers/37722960PubMed
1938816232Neoantigen-specific stimulation of tumor-infiltrating lymphocytes enables effective TCR isolation and expansion while preserving stem-like memory phenotypes.J Immunother Cancer2024https://conductscience.org/library/papers/38816232PubMed
2033128876Central memory CD8+ T cells derive from stem-like Tcf7hi effector cells in the absence of cytotoxic differentiation.Immunity2020https://conductscience.org/library/papers/33128876PubMed

See all 45 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
41822509Overcoming heterogeneity and immunosuppression: novel strategies in adoptive therapy for biliary tract cancer.Front Immunol2026https://conductscience.org/library/papers/41822509

Source PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
PDCD15133PubTator's text mininghttps://conductscience.org/library/genes/5133NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40972018

GET https://conductscience.org/api/papers/v1/40972018/grants?page=2